Researchers find potential new target for eye disease therapy
This research is the first to describe a role for SARM1 in photoreceptor cell biology
Read More
Tag: Trinity College
New pharma Azadyne raises £1.5m for autoimmune disease treatment
The Trinity College spin-off has completed a £1.5-million funding round for its autoimmune treatments.
Read More
- Myomaker Bio unveils lab‑grown human muscle platform to transform drug testing
- Survodutide delivers 16.6% weight loss in major phase 3 obesity trial
- Kahimmune Therapeutics signs collaboration agreement with Gustave Roussy
- BioDuro and CTI Biotechnology form partnership to accelerate preclinical drug development
- Asgard Therapeutics to present new preclinical data on AT‑108 at ASGCT 2026
